204 related articles for article (PubMed ID: 8438425)
1. Prospective randomized comparison of quadruple vs triple therapy for first cadaver transplants with immediate function.
Johnson CP; Slakey DP; Callaluce RD; Browne BJ; Roza AM; Adams MB
Transplant Proc; 1993 Feb; 25(1 Pt 1):585-6. PubMed ID: 8438425
[No Abstract] [Full Text] [Related]
2. Prospective randomized study of quadruple versus triple therapy in long-term kidney allografts.
Fruchaud G; Buisson C; Abbou C; Desvaux D; Baron C; Benmaadi A; Chopin D; Bourgeon B; Dahmane D; Rostoker G; Weil B; Lang P
Transplant Proc; 1996 Oct; 28(5):2819. PubMed ID: 8908077
[No Abstract] [Full Text] [Related]
3. Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy.
Canafax DM; Carleton BC; Matas AJ; Payne WD; Dunn DL; Sutherland DE; Najarian JS
Transplant Proc; 1993 Feb; 25(1 Pt 2):1692-3. PubMed ID: 8442239
[No Abstract] [Full Text] [Related]
4. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
Slakey DP; Johnson CP; Callaluce RD; Browne BJ; Zhu YR; Roza AM; Adams MB
Transplantation; 1993 Oct; 56(4):827-31. PubMed ID: 8212201
[TBL] [Abstract][Full Text] [Related]
5. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
[TBL] [Abstract][Full Text] [Related]
6. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
[No Abstract] [Full Text] [Related]
7. Predictors of improved outcome in second pediatric renal transplant recipients.
Moss A; Almond PS; Matas AJ; Gillingham K; Najarian JS
Transplant Proc; 1993 Feb; 25(1 Pt 1):597. PubMed ID: 8438429
[No Abstract] [Full Text] [Related]
8. Cyclosporine therapy in pancreas transplantation.
Davidson I; Lu C; Melone D; Risser R
Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
[No Abstract] [Full Text] [Related]
9. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
[No Abstract] [Full Text] [Related]
10. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
11. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
[No Abstract] [Full Text] [Related]
12. Use of Markov modeling for evaluating the cost-effectiveness of immunosuppressive therapies in renal transplant recipients.
Lewis RL; Canafax DM; Pettit KG; DiCesare J; Kaniecki DJ; Arnold RJ; Roberts MS
Transplant Proc; 1996 Aug; 28(4):2214-7. PubMed ID: 8769203
[No Abstract] [Full Text] [Related]
13. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee.
Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424
[No Abstract] [Full Text] [Related]
14. Transplantation in Singapore.
Vathsala A; Lee WT; Li MK; Woo KT; Lim CH
Transplant Proc; 1995 Feb; 27(1):1472-5. PubMed ID: 7878947
[No Abstract] [Full Text] [Related]
15. Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
Hoshinaga K; Shiroki R; Higuchi T; Horiba Y; Yanaoka M; Naide Y
Transplant Proc; 1996 Jun; 28(3):1591-3. PubMed ID: 8658798
[No Abstract] [Full Text] [Related]
16. Double-therapy vs triple-therapy immunosuppression in cadaveric renal transplants.
Carmellini M; Romagnoli J; Pietrabissa A; Di Stefano R; Oleggini M; Rindi P; Rizzo G; Mosca F
Transplant Proc; 1994 Oct; 26(5):2546-7. PubMed ID: 7940785
[No Abstract] [Full Text] [Related]
17. Renal allograft function and results with cyclosporine immunosuppression in recipients of single kidneys from cadaveric donors aged 12 to 24 months.
Banowsky LH; Wright FH; Kothmann R; Floyd M; Vick S
Transplant Proc; 1996 Aug; 28(4):2121-4. PubMed ID: 8769175
[No Abstract] [Full Text] [Related]
18. Combined kidney-pancreas and parathyroid transplantation: a case report.
Rahusen F; Munda R; Hariharan S; First MR; Demmy A
Clin Transplant; 1997 Aug; 11(4):341-3. PubMed ID: 9267727
[TBL] [Abstract][Full Text] [Related]
19. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
20. Chagas disease and transplantation.
Vazquez MC; Sabbatiello R; Schiavelli R; Maiolo E; Jacob N; Pattin M; Rearte A
Transplant Proc; 1996 Dec; 28(6):3301-3. PubMed ID: 8962281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
